LOS ANGELES, CA--(Marketwire - March 18, 2008) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process® designed to substantially reduce all types of pathogens in biological products including HIV, today announced that revenues for the 4th quarter period ending December 31, 2007 increased 100% to $0.32 million compared to $0.16 million in the 3rd quarter 2007.
